NCT03683771

Brief Summary

Despite constant progress in in vitro fertilization (IVF) techniques and ovarian stimulation, pregnancy and embryo implantation rates remain modest . The phenomenon of embryo implantation depends both on the embryo itself and on endometrial receptivity

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 25, 2018

Completed
3 days until next milestone

Study Start

First participant enrolled

September 28, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2019

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2019

Completed
Last Updated

January 9, 2019

Status Verified

January 1, 2019

Enrollment Period

5 months

First QC Date

September 22, 2018

Last Update Submit

January 8, 2019

Conditions

Infertility

Outcome Measures

Primary Outcomes (1)

  • The number of patients who will have positive pregnancy rate

    patients who will get pregnant in ICSI cycle with measuring their doppler indices before ovum pick up

    within 2 months

Interventions

Transvaginal US with Doppler studyDIAGNOSTIC_TEST

Transvaginal Ultrasound with doppler study on endometrium will be made

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsinfertile women who will undergo ICSI
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

120 patients will be included in the study whom will meet the inclusion criteria.

You may qualify if:

  • \- Maternal age from 20 to 40 years. Women with BMI range from 20 - 35 Women diagnosed with primary infertility

You may not qualify if:

  • Maternal chronic medical disorder (diabetes mellitus or hypertension). Women diagnosed with autoimmune diseases or antiphospholipid syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kasralainy hospital

Cairo, Egypt

RECRUITING

Algazeerah and Kasralainy hospital

Giza, Egypt

NOT YET RECRUITING

MeSH Terms

Conditions

Infertility

Interventions

Echocardiography, Doppler

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

EchocardiographyCardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyUltrasonography, DopplerHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Mahmoud Alalfy

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    STUDY CHAIR

Central Study Contacts

Mahmoud Alalfy

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2018

First Posted

September 25, 2018

Study Start

September 28, 2018

Primary Completion

February 15, 2019

Study Completion

February 20, 2019

Last Updated

January 9, 2019

Record last verified: 2019-01

Locations

EG(2)